Luis E. Raez, MD, discusses the current liquid biopsy options for patients with lung cancer through assessing circulating ...
Since the discovery of cell-free DNA (cfDNA) in 1948, shedded DNA fragments have been applied to technologies ranging from pre-natal genetic screening and ...
In a paper recently published in the journal Acta Neuropathologica Communications, DetermaCNI showed promise as a liquid biopsy method for diagnosing and profiling central nervous system tumors by ...
LMNTIC Biotech develops liquid biopsy technology to isolate rare tumor cells in blood LMNTIC Biotech pioneers novel ...
Jacob E. Berchuck, MD, discusses how a new epigenomic platform may influence the accessibility of PSMA-based therapies, especially for patients who may not have easy access to PSMA PET scans.
Global Refractory Follicular Lymphoma Diagnostics Market Projected to Reach USD 464.47 Million by 2029 Refractory Follicular ...
BioMark Expands Its Liquid Biopsy Platform Receptor Status for Breast Cancer Vancouver, British Columbia--(Newsfile Corp. - December 10, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC ...
PanGIA Biotech–a pioneer in liquid biopsy technology–today announced its first international partnership, collaborating with Canary Oncoceutics (Canar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback